Drug Discontinuation

 

HPS Pharmacies wish to advise that Sanofi-Aventis Australia has given notice of the discontinuation of:

ImmuCyst® Vials
Bacillus Calmette and Guérin (BCG) sub-strain Connaught
ARTG 168005

ImmuCyst® is currently in short supply and global production is to be discontinued from mid-2017. OncoTice® (Bacillus Calmette and Guérin [BCG] sub-strain Tice) is currently available. However, it should be noted that ImmuCyst® and OncoTice® are not interchangeable. Additional references should be consulted for further information.

Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your facility and clinicians if there is an immediate impact to your facility.

Please retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sanofi-Aventis Australia on 1800 818 806.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates